Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 1993Antimicrobial Agents and Chemotherapy

In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms

View Full Paper
Ask AI
Bookmark
Share

Authors

LCL A CollinsLouisiana State UniversityGMG J MalanoskiDeaconess HospitalGEGeorge M. EliopoulosHarvard University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Collins et al. (1993) studied this question.

synapsesocial.com/papers/6a65a0c666b3f59c44c4d9dfhttps://doi.org/10.1128/aac.37.3.598
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 595001992 · 61 citations
  2. 2National Committee for Clinical Laboratory Standards1980 · 14,792 citations
  3. 3In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci1991 · 81 citations
  4. 4Comparative in-vitro activity of RP 595001992 · 33 citations
  5. 5The in-vitro activity of RP 59500 against Gram-positive cocci1992 · 37 citations